An anonymous director reports

MINDMED TO HOST CONFERENCE CALL AND WEBCAST TO DISCUSS 2023 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE

Mind Medicine (MindMed) Inc. plans to host a conference call and webcast on Wednesday, Feb. 28, 2024, at 8 a.m. ET to provide a corporate update and review the company's results for the year ended Dec. 31, 2023.

A replay of the webcast will be available via the investor relations section of the Mind Medicine website and archived for at least 30 days after the webcast. Those who plan on participating are advised to join 15 minutes prior to the start time.

About Mind Medicine (MindMed) Inc.

Mind Medicine is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain-health disorders. Mind Medicine's mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. The company is developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems.